Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity
Background Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of t...
Saved in:
Published in | Molecular biology reports Vol. 50; no. 5; pp. 4723 - 4728 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.05.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.
Methods and results
Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m
2
) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.
Conclusion
Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO. |
---|---|
AbstractList | Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.BACKGROUNDAmong the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m2) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.METHODS AND RESULTSMen and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m2) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO.CONCLUSIONOur results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO. BACKGROUND: Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. METHODS AND RESULTS: Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m²) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. CONCLUSION: Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO. Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m ) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO. BackgroundAmong the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO.Methods and resultsMen and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m2) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO.ConclusionOur results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO. Background Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic inflammation; however, they are not been investigated in subjects with metabolically healthy obesity (MHO). Thus, the objective of this study was to determine the association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with MHO. Methods and results Men and women with obesity aged 20 to 55 years were enrolled in a cross-sectional study. Individuals with MHO were allocated into the groups with and without low-grade chronic inflammation. Pregnancy, smoking, alcohol consumption, intense physical activity or sexual intercourse in the previous 72 h, diabetes, high blood pressure, cancer, thyroid disease, acute or chronic infections, renal impairment, and hepatic diseases, were exclusion criteria. The MHO phenotype was defined by a body mass index (BMI ≥ 30 kg/m 2 ) plus one or none of the following cardiovascular risk factors: hyperglycemia, elevated blood pressure, hypertriglyceridemia, and low high-density lipoprotein cholesterol. A total of 64 individuals with MHO were enrolled and allocated into the groups with (n = 37) and without (n = 27) inflammation. The multiple logistic regression analysis indicated that TLR2 expression is significantly associated with inflammation in individuals with MHO. In the subsequent analysis adjusted by BMI, TLR2 expression remained associated with inflammation in individuals with MHO. Conclusion Our results suggest that overexpression of TLR2, but not TLR4 and MyD88, is associated with low-grade chronic inflammation in subjects with MHO. |
Author | Morales-Gurrola, Francisco G. Salas-Leal, Alma Cristina Guerrero-Romero, Fernando Simental-Mendía, Luis E. Salas-Pacheco, Jose M. Castellanos-Juárez, Francisco X. |
Author_xml | – sequence: 1 givenname: Fernando surname: Guerrero-Romero fullname: Guerrero-Romero, Fernando organization: Unidad de Investigación Biomédica, Instituto Mexicano del Seguro Social – sequence: 2 givenname: Francisco X. surname: Castellanos-Juárez fullname: Castellanos-Juárez, Francisco X. organization: Institute of Scientific Research, Juarez University of the State of Durango – sequence: 3 givenname: Jose M. surname: Salas-Pacheco fullname: Salas-Pacheco, Jose M. organization: Institute of Scientific Research, Juarez University of the State of Durango – sequence: 4 givenname: Francisco G. surname: Morales-Gurrola fullname: Morales-Gurrola, Francisco G. organization: Unidad de Investigación Biomédica, Instituto Mexicano del Seguro Social, Institute of Scientific Research, Juarez University of the State of Durango – sequence: 5 givenname: Alma Cristina surname: Salas-Leal fullname: Salas-Leal, Alma Cristina organization: Institute of Scientific Research, Juarez University of the State of Durango – sequence: 6 givenname: Luis E. orcidid: 0000-0002-3617-4921 surname: Simental-Mendía fullname: Simental-Mendía, Luis E. email: luis_simental81@hotmail.com organization: Unidad de Investigación Biomédica, Instituto Mexicano del Seguro Social |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36905405$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9u1DAQhy1URLeFF-CALHHh0MA4dhzvsSp_pUVIqJwjx540rpJ4sR2W9C14Y5KmgNRDkWyPZH2_8VjfCTka_ICEPGfwmgGUbyJjwHkG-bwV5yq7eUQ2rCh5JralOiIb4MAyoQp2TE5ivAYAwcriCTnmcguFgGJDfp3H6I3TyfmB1pgOiANNLVL8uQ8Y43LtG3q5-yrOljM_o3qw9PP0Vil6cKmlnT9kV0FbpKYNfnCGuqHpdN-vPd2yrPvh7Ki7uEZ6TLr2nTO66ybaou5SO1FfY3RpekoeNzOJz-7qKfn2_t3lxcds9-XDp4vzXWYEqJQxaRWUDUojEbCWWNSGbbc1NkZIboSxYJnN5dYCWGGkAlbWVlrTWIG8zPkpebX23Qf_fcSYqt5Fg12nB_RjrDgrOCvVUv6H5qWSDJiQckZf3kOv_RiG-SNVPs-b51yIhXpxR411j7baB9frMFV_vMxAvgIm-BgDNn8RBtUiv1rlV7P86lZ-dTOH1L2QcenWQgradQ9H-RqN8zvDFYZ_Yz-Q-g2DTcS3 |
CitedBy_id | crossref_primary_10_1007_s00774_025_01594_y crossref_primary_10_1038_s41575_023_00867_z crossref_primary_10_3389_frmbi_2024_1324476 crossref_primary_10_1007_s11657_024_01424_0 crossref_primary_10_1016_j_biochi_2025_01_008 crossref_primary_10_1016_j_surg_2023_07_002 crossref_primary_10_1186_s12889_024_20243_z crossref_primary_10_1016_j_intimp_2024_111551 crossref_primary_10_3389_fendo_2023_1191501 crossref_primary_10_1007_s10067_024_07179_w crossref_primary_10_1302_2046_3758_1310_BJR_2023_0366_R1 |
Cites_doi | 10.3109/13813455.2011.562514 10.1038/SJ.IJO.0801792 10.1002/JCSM.12159 10.2337/DC11-2375 10.1210/JC.2014-3885 10.1016/S0140-6736(10)62037-5 10.1038/OBY.2003.74 10.1080/13813450802181047 10.1016/J.METABOL.2019.01.003 10.1007/S00125-010-1747-3 10.1139/Y11-071 10.3390/metabo10020048 10.1677/JOE-08-0354 10.2337/DC09-1799 10.1097/MD.0000000000003384 10.2337/DB20-0591 10.1089/MET.2008.0034 10.1210/ENDREV/BNAA004 10.1210/JC.2005-0482 10.1159/000191413 10.3389/FIMMU.2014.00461 10.1385/IR:34:3:193 10.1016/J.DIABRES.2004.11.007 10.1373/49.4.666 10.1210/JC.2010-0288 10.1038/OBY.2008.25 10.1111/J.2047-6310.2012.00098.X 10.1038/SJ.IJO.0803304 10.1371/JOURNAL.PONE.0265362 10.7554/ELIFE.31377 10.3389/FENDO.2022.886957 10.1186/1476-9255-9-48 10.1210/JC.2013-2038 10.1097/MD.0000000000008838 10.1161/CIRCULATIONAHA.109.192644 10.1161/01.HYP.0000107251.49515.C2 10.1186/S12950-014-0039-Y 10.1371/JOURNAL.PONE.0121971 10.1371/JOURNAL.PONE.0214468 10.1161/JAHA.115.002823 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature B.V. 2023 2023. The Author(s), under exclusive licence to Springer Nature B.V. The Author(s), under exclusive licence to Springer Nature B.V. 2023. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2023 – notice: 2023. The Author(s), under exclusive licence to Springer Nature B.V. – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2023. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7TM 7X7 7XB 88A 88E 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 7S9 L.6 |
DOI | 10.1007/s11033-023-08338-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic AGRICOLA MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1573-4978 |
EndPage | 4728 |
ExternalDocumentID | 36905405 10_1007_s11033_023_08338_z |
Genre | Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 123 1SB 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88A 88E 88I 8AO 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LK8 LLZTM M0L M1P M2P M4Y M7P MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK6 WK8 YLTOR Z45 Z7U Z7V Z7W Z7Y Z82 Z83 Z87 Z8O Z8P Z8Q Z8S Z8V Z8W Z91 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM AAPKM AAYXX ABAKF ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7TK 7TM 7XB 8FD 8FK ABRTQ FR3 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c408t-16d807fe6c6e0eb6e5bc199befc463c4cd0d1d269d00d4c68017bd6dcfd4e3723 |
IEDL.DBID | U2A |
ISSN | 0301-4851 1573-4978 |
IngestDate | Tue Aug 05 09:59:32 EDT 2025 Fri Jul 11 04:13:44 EDT 2025 Fri Jul 25 18:55:45 EDT 2025 Wed Feb 19 02:24:51 EST 2025 Tue Jul 01 03:18:28 EDT 2025 Thu Apr 24 23:02:40 EDT 2025 Fri Feb 21 02:45:30 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Obesity Inflammation TLR Metabolically healthy obesity MyD88 |
Language | English |
License | 2023. The Author(s), under exclusive licence to Springer Nature B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c408t-16d807fe6c6e0eb6e5bc199befc463c4cd0d1d269d00d4c68017bd6dcfd4e3723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-3617-4921 |
PMID | 36905405 |
PQID | 2807223446 |
PQPubID | 54080 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_3153178315 proquest_miscellaneous_2786101466 proquest_journals_2807223446 pubmed_primary_36905405 crossref_primary_10_1007_s11033_023_08338_z crossref_citationtrail_10_1007_s11033_023_08338_z springer_journals_10_1007_s11033_023_08338_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230500 2023-05-00 2023-May 20230501 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 5 year: 2023 text: 20230500 |
PublicationDecade | 2020 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
PublicationSubtitle | An International Journal on Molecular and Cellular Biology |
PublicationTitle | Molecular biology reports |
PublicationTitleAbbrev | Mol Biol Rep |
PublicationTitleAlternate | Mol Biol Rep |
PublicationYear | 2023 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Dasu, Devaraj, Park, Jialal (CR22) 2010; 33 Park, Park, Yu (CR31) 2005; 69 CR19 CR18 Vitseva, Tanriverdi, Tchkonia (CR11) 2008; 16 Guo, Zhang, Liu (CR30) 2021; 70 Shin, Hyun, Kim (CR36) 2006; 30 Jung, Lee, Kang (CR37) 2015; 100 Kim, Seo, Cho (CR2) 2016; 95 CR13 CR12 CR10 Hardy, Kim, Ciccarelli (CR20) 2013; 8 Karelis, Faraj, Bastard (CR8) 2005; 90 Simental-Mendía, Rodríguez-Morán, Guerrero-Romero (CR16) 2008; 6 Bulló, García-Lorda, Megias, Salas-Salvadó (CR34) 2003; 11 Mullick, Tobias, Curtiss (CR26) 2006; 34 Guerrero-Romero, Simental-Mendía, González-Ortiz (CR15) 2010; 95 Brandão, Martins, Monteiro (CR1) 2020; 10 CR4 Kawasaki, Kawai (CR24) 2014 CR6 Fresno, Alvarez, Cuesta (CR9) 2011; 117 CR5 Rifai, Ridker (CR14) 2003; 49 Gonzalez, Heymsfield (CR17) 2017; 8 Jialal, Huet, Kaur (CR21) 2012; 35 CR7 Blüher (CR39) 2020; 41 Ehses, Meier, Wueest (CR29) 2010; 53 Erridge (CR25) 2009; 1 Finucane, Stevens, Cowan (CR3) 2011; 377 CR23 CR41 CR40 Kouvari, Panagiotakos, Yannakoulia (CR38) 2019; 93 Caricilli, Nascimento, Pauli (CR28) 2008; 199 Nieto-Vazquez, Fernández-Veledo, Krämer (CR35) 2008; 114 Festa, D’Agostino, Williams (CR33) 2001; 25 Bastard, Maachi, Lagathu (CR32) 2006; 17 Hasu, Thabet, Tam, Whitman (CR27) 2011; 89 J-P Bastard (8338_CR32) 2006; 17 OI Vitseva (8338_CR11) 2008; 16 8338_CR13 MC Gonzalez (8338_CR17) 2017; 8 NH Kim (8338_CR2) 2016; 95 8338_CR19 F Guerrero-Romero (8338_CR15) 2010; 95 8338_CR18 I Nieto-Vazquez (8338_CR35) 2008; 114 8338_CR12 MR Dasu (8338_CR22) 2010; 33 8338_CR10 AM Caricilli (8338_CR28) 2008; 199 M Fresno (8338_CR9) 2011; 117 OT Hardy (8338_CR20) 2013; 8 AE Mullick (8338_CR26) 2006; 34 C Erridge (8338_CR25) 2009; 1 8338_CR6 8338_CR7 AD Karelis (8338_CR8) 2005; 90 HS Park (8338_CR31) 2005; 69 T Kawasaki (8338_CR24) 2014 LE Simental-Mendía (8338_CR16) 2008; 6 M Bulló (8338_CR34) 2003; 11 N Rifai (8338_CR14) 2003; 49 MM Finucane (8338_CR3) 2011; 377 I Jialal (8338_CR21) 2012; 35 Z Guo (8338_CR30) 2021; 70 8338_CR4 8338_CR5 8338_CR41 8338_CR40 I Brandão (8338_CR1) 2020; 10 8338_CR23 A Festa (8338_CR33) 2001; 25 CH Jung (8338_CR37) 2015; 100 JA Ehses (8338_CR29) 2010; 53 M Hasu (8338_CR27) 2011; 89 M Blüher (8338_CR39) 2020; 41 MJ Shin (8338_CR36) 2006; 30 M Kouvari (8338_CR38) 2019; 93 |
References_xml | – volume: 117 start-page: 151 year: 2011 end-page: 164 ident: CR9 article-title: Toll-like receptors, inflammation, metabolism and obesity publication-title: Arch Physiol Biochem doi: 10.3109/13813455.2011.562514 – volume: 25 start-page: 1407 year: 2001 end-page: 1415 ident: CR33 article-title: The relation of body fat mass and distribution to markers of chronic inflammation publication-title: Int J Obes Relat Metab Disord doi: 10.1038/SJ.IJO.0801792 – ident: CR18 – volume: 8 start-page: 187 year: 2017 end-page: 189 ident: CR17 article-title: Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/JCSM.12159 – volume: 35 start-page: 900 year: 2012 end-page: 904 ident: CR21 article-title: Increased toll-like receptor activity in patients with metabolic syndrome publication-title: Diabetes Care doi: 10.2337/DC11-2375 – volume: 100 start-page: 934 year: 2015 end-page: 941 ident: CR37 article-title: The risk of incident type 2 diabetes in a korean metabolically healthy obese population: the role of systemic inflammation publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2014-3885 – volume: 377 start-page: 557 year: 2011 end-page: 567 ident: CR3 article-title: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants publication-title: Lancet (London England) doi: 10.1016/S0140-6736(10)62037-5 – volume: 11 start-page: 525 year: 2003 end-page: 531 ident: CR34 article-title: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression publication-title: Obes Res doi: 10.1038/OBY.2003.74 – ident: CR4 – ident: CR12 – volume: 114 start-page: 183 year: 2008 end-page: 194 ident: CR35 article-title: Insulin resistance associated to obesity: the link TNF-alpha publication-title: Arch Physiol Biochem doi: 10.1080/13813450802181047 – volume: 93 start-page: 18 year: 2019 end-page: 24 ident: CR38 article-title: Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study publication-title: Metabolism doi: 10.1016/J.METABOL.2019.01.003 – ident: CR10 – volume: 53 start-page: 1795 year: 2010 end-page: 1806 ident: CR29 article-title: Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet publication-title: Diabetologia doi: 10.1007/S00125-010-1747-3 – volume: 17 start-page: 4 year: 2006 end-page: 12 ident: CR32 article-title: Recent advances in the relationship between obesity, inflammation, and insulin resistance publication-title: Eur Cytokine Netw – ident: CR6 – volume: 89 start-page: 737 year: 2011 end-page: 742 ident: CR27 article-title: Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice publication-title: Can J Physiol Pharmacol doi: 10.1139/Y11-071 – ident: CR40 – ident: CR23 – volume: 10 start-page: 48 year: 2020 ident: CR1 article-title: Metabolically healthy obesity—heterogeneity in definitions and unconventional factors publication-title: Metabolites doi: 10.3390/metabo10020048 – volume: 199 start-page: 399 year: 2008 end-page: 406 ident: CR28 article-title: Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet publication-title: J Endocrinol doi: 10.1677/JOE-08-0354 – volume: 33 start-page: 861 year: 2010 end-page: 868 ident: CR22 article-title: Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects publication-title: Diabetes Care doi: 10.2337/DC09-1799 – ident: CR19 – volume: 95 start-page: e3384 year: 2016 ident: CR2 article-title: Risk of the Development of Diabetes and Cardiovascular Disease in metabolically healthy obese people publication-title: Med (Baltim) doi: 10.1097/MD.0000000000003384 – ident: CR13 – volume: 70 start-page: 2107 year: 2021 end-page: 2119 ident: CR30 article-title: Toll-like receptor 2 (TLR2) knockout abrogates Diabetic and obese phenotypes while restoring endothelial function via inhibition of NOX1 publication-title: Diabetes doi: 10.2337/DB20-0591 – volume: 6 start-page: 299 year: 2008 end-page: 304 ident: CR16 article-title: The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects publication-title: Metab Syndr Relat Disord doi: 10.1089/MET.2008.0034 – volume: 41 start-page: 405 year: 2020 end-page: 420 ident: CR39 article-title: Metabolically healthy obesity publication-title: Endocr Rev doi: 10.1210/ENDREV/BNAA004 – volume: 90 start-page: 4145 year: 2005 end-page: 4150 ident: CR8 article-title: The metabolically healthy but obese individual presents a favorable inflammation profile publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2005-0482 – volume: 1 start-page: 340 year: 2009 end-page: 349 ident: CR25 article-title: The roles of toll-like receptors in atherosclerosis publication-title: J Innate Immun doi: 10.1159/000191413 – ident: CR5 – year: 2014 ident: CR24 article-title: Toll-like receptor signaling pathways publication-title: Front Immunol doi: 10.3389/FIMMU.2014.00461 – volume: 34 start-page: 193 year: 2006 end-page: 209 ident: CR26 article-title: Toll-like receptors and atherosclerosis: key contributors in disease and health? publication-title: Immunol Res doi: 10.1385/IR:34:3:193 – volume: 69 start-page: 29 year: 2005 end-page: 35 ident: CR31 article-title: Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6 publication-title: Diabetes Res Clin Pract doi: 10.1016/J.DIABRES.2004.11.007 – ident: CR7 – volume: 49 start-page: 666 year: 2003 end-page: 669 ident: CR14 article-title: Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation publication-title: Clin Chem doi: 10.1373/49.4.666 – volume: 95 start-page: 3347 year: 2010 end-page: 3351 ident: CR15 article-title: The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2010-0288 – volume: 16 start-page: 932 year: 2008 end-page: 937 ident: CR11 article-title: Inducible toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue publication-title: Obes (Silver Spring) doi: 10.1038/OBY.2008.25 – ident: CR41 – volume: 8 start-page: e19 year: 2013 end-page: e23 ident: CR20 article-title: Increased toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents publication-title: Pediatr Obes doi: 10.1111/J.2047-6310.2012.00098.X – volume: 30 start-page: 1529 year: 2006 end-page: 1534 ident: CR36 article-title: Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women publication-title: Int J Obes (Lond) doi: 10.1038/SJ.IJO.0803304 – ident: 8338_CR40 doi: 10.1371/JOURNAL.PONE.0265362 – ident: 8338_CR10 doi: 10.7554/ELIFE.31377 – volume: 25 start-page: 1407 year: 2001 ident: 8338_CR33 publication-title: Int J Obes Relat Metab Disord doi: 10.1038/SJ.IJO.0801792 – volume: 8 start-page: 187 year: 2017 ident: 8338_CR17 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/JCSM.12159 – volume: 377 start-page: 557 year: 2011 ident: 8338_CR3 publication-title: Lancet (London England) doi: 10.1016/S0140-6736(10)62037-5 – volume: 89 start-page: 737 year: 2011 ident: 8338_CR27 publication-title: Can J Physiol Pharmacol doi: 10.1139/Y11-071 – year: 2014 ident: 8338_CR24 publication-title: Front Immunol doi: 10.3389/FIMMU.2014.00461 – volume: 41 start-page: 405 year: 2020 ident: 8338_CR39 publication-title: Endocr Rev doi: 10.1210/ENDREV/BNAA004 – volume: 1 start-page: 340 year: 2009 ident: 8338_CR25 publication-title: J Innate Immun doi: 10.1159/000191413 – ident: 8338_CR41 doi: 10.3389/FENDO.2022.886957 – volume: 93 start-page: 18 year: 2019 ident: 8338_CR38 publication-title: Metabolism doi: 10.1016/J.METABOL.2019.01.003 – volume: 95 start-page: e3384 year: 2016 ident: 8338_CR2 publication-title: Med (Baltim) doi: 10.1097/MD.0000000000003384 – ident: 8338_CR23 doi: 10.1186/1476-9255-9-48 – volume: 11 start-page: 525 year: 2003 ident: 8338_CR34 publication-title: Obes Res doi: 10.1038/OBY.2003.74 – volume: 6 start-page: 299 year: 2008 ident: 8338_CR16 publication-title: Metab Syndr Relat Disord doi: 10.1089/MET.2008.0034 – volume: 69 start-page: 29 year: 2005 ident: 8338_CR31 publication-title: Diabetes Res Clin Pract doi: 10.1016/J.DIABRES.2004.11.007 – ident: 8338_CR7 doi: 10.1210/JC.2013-2038 – volume: 117 start-page: 151 year: 2011 ident: 8338_CR9 publication-title: Arch Physiol Biochem doi: 10.3109/13813455.2011.562514 – volume: 33 start-page: 861 year: 2010 ident: 8338_CR22 publication-title: Diabetes Care doi: 10.2337/DC09-1799 – volume: 199 start-page: 399 year: 2008 ident: 8338_CR28 publication-title: J Endocrinol doi: 10.1677/JOE-08-0354 – ident: 8338_CR4 doi: 10.1097/MD.0000000000008838 – volume: 95 start-page: 3347 year: 2010 ident: 8338_CR15 publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2010-0288 – ident: 8338_CR12 doi: 10.1161/CIRCULATIONAHA.109.192644 – ident: 8338_CR18 doi: 10.1161/01.HYP.0000107251.49515.C2 – ident: 8338_CR19 doi: 10.1186/S12950-014-0039-Y – volume: 10 start-page: 48 year: 2020 ident: 8338_CR1 publication-title: Metabolites doi: 10.3390/metabo10020048 – volume: 34 start-page: 193 year: 2006 ident: 8338_CR26 publication-title: Immunol Res doi: 10.1385/IR:34:3:193 – volume: 16 start-page: 932 year: 2008 ident: 8338_CR11 publication-title: Obes (Silver Spring) doi: 10.1038/OBY.2008.25 – volume: 100 start-page: 934 year: 2015 ident: 8338_CR37 publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2014-3885 – ident: 8338_CR5 doi: 10.1371/JOURNAL.PONE.0121971 – ident: 8338_CR13 doi: 10.1371/JOURNAL.PONE.0214468 – volume: 49 start-page: 666 year: 2003 ident: 8338_CR14 publication-title: Clin Chem doi: 10.1373/49.4.666 – volume: 70 start-page: 2107 year: 2021 ident: 8338_CR30 publication-title: Diabetes doi: 10.2337/DB20-0591 – volume: 30 start-page: 1529 year: 2006 ident: 8338_CR36 publication-title: Int J Obes (Lond) doi: 10.1038/SJ.IJO.0803304 – volume: 90 start-page: 4145 year: 2005 ident: 8338_CR8 publication-title: J Clin Endocrinol Metab doi: 10.1210/JC.2005-0482 – volume: 114 start-page: 183 year: 2008 ident: 8338_CR35 publication-title: Arch Physiol Biochem doi: 10.1080/13813450802181047 – volume: 8 start-page: e19 year: 2013 ident: 8338_CR20 publication-title: Pediatr Obes doi: 10.1111/J.2047-6310.2012.00098.X – volume: 53 start-page: 1795 year: 2010 ident: 8338_CR29 publication-title: Diabetologia doi: 10.1007/S00125-010-1747-3 – volume: 17 start-page: 4 year: 2006 ident: 8338_CR32 publication-title: Eur Cytokine Netw – ident: 8338_CR6 doi: 10.1161/JAHA.115.002823 – volume: 35 start-page: 900 year: 2012 ident: 8338_CR21 publication-title: Diabetes Care doi: 10.2337/DC11-2375 |
SSID | ssj0004175 |
Score | 2.4049373 |
Snippet | Background
Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade... Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade chronic... BackgroundAmong the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with low-grade... BACKGROUND: Among the Toll-like receptors (TLR) that are dependent of myeloid response protein (MyD88), the TLR4 and TLR2 are directly associated with... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4723 |
SubjectTerms | Adaptor Proteins, Signal Transducing - metabolism alcohol drinking Animal Anatomy Animal Biochemistry Biomedical and Life Sciences Blood pressure Body Mass Index Cardiovascular diseases Cholesterol Cross-Sectional Studies diabetes Diabetes mellitus Female High density lipoprotein high density lipoprotein cholesterol Histology Humans Hyperglycemia Hypertension Hypertension - metabolism Hypertriglyceridemia Inflammation Inflammation - genetics Life Sciences Liver diseases Morphology MyD88 protein Myeloid Differentiation Factor 88 - genetics Myeloid Differentiation Factor 88 - metabolism Obesity Obesity, Metabolically Benign phenotype Phenotypes Physical activity pregnancy regression analysis risk Risk Factors Sexual intercourse Short Communication Thyroid cancer Thyroid diseases TLR2 protein TLR4 protein Toll-Like Receptor 2 - genetics Toll-Like Receptor 2 - metabolism Toll-like receptors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BEaIXBOUrUJCRuLERceK1kxNChapClANqpb1FscdBlZakdLcq23_BP2YmdnZBFXtJFMWWLM-zZzyemQfwptXSWeToGaxMqkhFppaOQrTiy8JPW9fiQAZz_FUfnarPs-ksOtwWMaxy3BOHjRp7xz7yd1y1hVQZnV7en_9MmTWKb1cjhcZtuMOlyziky8zMJi9SDoV22epPFZkWMWkmpM5JZjEjjcX1mWnRX_-rmG5YmzduSgcFdPgA7kfLUXwIon4It3y3B3cDl-RqD-4djNRtj-D3X5MuYiSWIEtP-F8x7rUTfStOvnxTE37mE9F0KI5XH8tSsGdWzPur9PtFg164UD1XEBIJPCHRkT7E2TqTaxG6_PBLAhT7AOfzlQj5lSvRB-KBx3B6-Onk4CiN3AupU1m5TKVGmvDWa6d95q32U-tkVVnfOqULpxxmKDHXFWYZKqdJ0RmLGkm4yhcmL57ATtd3_hkIYww6JyVK26opmkZi0VSZswQFJ_M8ATlOfO1iYXLmx5jXm5LKLKyahFUPwqqvE3i77nMeynJsbb0_yrOOS3RRbwCVwOv1bxIU35g0ne8vqY0pNZMZ6y1tCtIZ0pT0SuBpwMp6SIWuBpM4gckIns0A_j_e59vH-wJ28wG4HHa5DzvLi0v_kkyjpX014P8PZ_0KeQ priority: 102 providerName: ProQuest |
Title | Association between the expression of TLR4, TLR2, and MyD88 with low-grade chronic inflammation in individuals with metabolically healthy obesity |
URI | https://link.springer.com/article/10.1007/s11033-023-08338-z https://www.ncbi.nlm.nih.gov/pubmed/36905405 https://www.proquest.com/docview/2807223446 https://www.proquest.com/docview/2786101466 https://www.proquest.com/docview/3153178315 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9swED7WlrG-lK375a4LGuxtMVi2LNmPWZeubGsZpYHsyVg6uQwyuzQpW_pf9D_uybKTjW6FvVgYn43QffKdpLv7AN5WkhuNLnoGcxUKMpGhpqUQzfgssWllKmzJYI5P5NFEfJqm0y4pbN5Hu_dHku2fep3sxh3vGNkYV1GZpun1Bmylbu1OKJ7Eo3U2JG_L6zpfPxTkUHSpMn__xp_m6I6Peed8tDU7h49hp_MX2cgr-Ak8sPUuPPQMkstdeHTQE7Y9hZvfhpp18VeM_Dtmf3XRrjVrKnb25VQM3TUesrJGdrz8kGXM7ceyWfMzPL8s0TLja-Yywh9Bxqc30g37vsrfmvtXftgFwcjt_M1mS-azKpes8XQDz2ByOD47OAo7xoXQiChbhFxiFqnKSiNtZLW0qTY8z7WtjJCJEQYj5BjLHKMIhZFk3pRGiaRSYRMVJ89hs25q-xKYUgqN4Ry5rkSKquSYlHlkNAHA8DgOgPcDX5iuHLljxZgV60LKTlkFKatolVVcB_Bu9c6FL8Zxr_R-r8-im5jzwhX_IY-IFsEBvFk9JkW5c5Kyts0VyahMOgpjeY9MQpaCq4yaAF54rKy6lMi8dYQDGPbgWXfg3_3d-z_xV7Adt0B2wZf7sLm4vLKvyUFa6AFsqKkawNbo47fPY2rfj0--ng7aWXIL2agL_Q |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqVC5ICgvQ4FFghOx8NqbtX1ACPpQSpMIVanUm_HurBFSsEuTqrj_gj_Cb2TWayegitx6SRRlHY0y385jd2Y-gFeF5FqhrZ7BNPYFuUhfUSpEOz6JzKDQBTZkMOOJHJ6IT6eD0w343fXC2LLKziY2hhorbc_I39qpLeTKKHt5f_bDt6xR9na1o9BwsDgy9SWlbPN3h3uk39dheLA_3R36LauAr0WQLHwukX6qMFJLExglzUBpnqbKFFrISAuNAXIMZYpBgEJLMuGxQokktjBRbAcdkMnfFBGlMj3Y_Lg_-Xy86sTkzWhfm2f4goKZtk3HNetxy5tGPtJOhCYzc_WvK7wW3167m21c3sFduNPGquyDA9c92DDlNtxy7JX1NmztdmRx9-HXX2pmbe0Xo9iSmZ9tpW3JqoJNR8eib1_DPstLZON6L0mYPQtms-rS_3qeo2HazetlhH2Cq2utpA_s27J3bO4e-W4WBGF76jib1cx1dNasclQHD-DkRvTyEHplVZrHwOI4Rq05R64KMcA45xjlaaAVgU_zMPSAd398pttR6JaRY5athjhbZWWkrKxRVnblwZvlM2duEMja1TudPrPWKMyzFYQ9eLn8mhRl72jy0lQXtCZOpKVPlmvWROSleJzQmwePHFaWIkUybYJwD_odeFYC_F_eJ-vlfQFbw-l4lI0OJ0dP4XbYgNgWfe5Ab3F-YZ5RYLZQz9vdwODLTW_AP2EhSlw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRTwuqBQooQWMBCc2apw4dnJACHVZtfQhhFppbyGxHYS0JKW7VUn_Rf8Ov64zcbILqthbLxut1omcnW8etmfmA3hTSq4LQ9kzJlW-QBfpF7gUQo1PIhuXujQtGczhkdw9EZ_H8XgF_vS1MJRW2dvE1lCbWtMe-TZ1bUFXhquX7bJLi_gyHH04_eUTgxSdtPZ0Gg4i-7a5wOXb9P3eEGX9NgxHn453dv2OYcDXIkhmPpcGH1taqaUNbCFtXGiepoUttZCRFtoEhptQpiYIjNASzbkqjDT4CsJGipoeoPm_o6KYk46psVrUZPK2yS-tOHyBYU1XsOPK9jgxqKG3pN7QaHAu_3WKNyLdG6e0rfMbrcHDLmplHx3MHsGKrdbhruOxbNbh_k5PG_cYrv4SOOuywBhGmcz-7nJuK1aX7PjgqxjQZzhgeWXYYTNMEka7wmxSX_jfz3JjmXadexlqAQLXFVniF_ZjXkU2dbf8tDMEM-0_TiYNc7WdDasd6cETOLkVqTyF1aqu7DNgSimjNeeGF6WIjcq5ifI00AXCUPMw9ID3f3ymu6boxM0xyRbtnElYGQora4WVXXrwbn7PqWsJsnT0Vi_PrDMP02wBZg9ez39GQdFpTV7Z-hzHqEQSkbJcMiZCf8VVghcPNhxW5lOKZNqG4x4MevAsJvD_-T5fPt9XcA_VLjvYO9rfhAdhi2HK_tyC1dnZuX2BEdqseNmqAoNvt6171yAsTSw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+the+expression+of+TLR4%2C+TLR2%2C+and+MyD88+with+low-grade+chronic+inflammation+in+individuals+with+metabolically+healthy+obesity&rft.jtitle=Molecular+biology+reports&rft.au=Guerrero-Romero%2C+Fernando&rft.au=Castellanos-Ju%C3%A1rez%2C+Francisco+X.&rft.au=Salas-Pacheco%2C+Jose+M.&rft.au=Morales-Gurrola%2C+Francisco+G.&rft.date=2023-05-01&rft.pub=Springer+Netherlands&rft.issn=0301-4851&rft.eissn=1573-4978&rft.volume=50&rft.issue=5&rft.spage=4723&rft.epage=4728&rft_id=info:doi/10.1007%2Fs11033-023-08338-z&rft.externalDocID=10_1007_s11033_023_08338_z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4851&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4851&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4851&client=summon |